ARCHIVES

ODAC Advice: Avoid ESAs In Curative Settings, Require Patients To Sign Informed Consent.

This article is from The Cancer Letter archive.

Vol. 34 No. 10 | March 14, 2008

Download PDF Visit The Full Archive

Related Articles

Almost Half of Faculty on IRBs Have Industry Ties, Study Finds

September 26, 2003

Tissue of Origin Test Consistent With Diagnosis In Blinded Validation Study

January 28, 2011

Clinical Trials Approved By NCI

November 26, 2010

Genentech Says Phase III Trial Shows Avastin Improved PFS For Ovarian Cancer

March 26, 2010

No More Free Cancergrams, But NCI Will Save a Bundle

October 17, 1986

Panel To Take Up Issues In Grant/Peer Review System, Consider NCAB Membership Requirements

December 11, 1981